<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Mehran, Roxana</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Ticagrelor Reduces Platelet Reactivity in Troponin Negative Patients With ACS Undergoing Non-Urgent PCI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-06-25 12:08:30</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5-6</style></pages><abstract><style  face="normal" font="default" size="100%">In low-risk patients with troponin-negative acute coronary syndromes undergoing ad hoc percutaneous coronary intervention, ticagrelor treatment resulted in greater reductions of platelet reactivity and a greater increase in inhibition of platelet aggregation compared with clopidogrel.</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>